FREE SHIPPING ON ORDERS OVER $150

direct-acting antiviral agents against hepatitis c virus and lipid metabolism for Treatment of Hepatitis C Virus-Lipid Interplay: Pathogenesis

$23.97

Quantity
- +
Description

After You Pay, We Will Arrange To Ship To You As Soon As Possible

direct-acting antiviral agents against hepatitis c virus and lipid metabolism for Treatment of Hepatitis C Virus-Lipid Interplay: Pathogenesis

RhoA activates purified phospholipase C- by a guanine nucleotide-dependent mechanism

direct-acting antiviral agents against hepatitis c virus and lipid metabolism for Treatment of Hepatitis C Virus-Lipid Interplay: Pathogenesis

7ce and Extended Data Fig

direct-acting antiviral agents against hepatitis c virus and lipid metabolism for Treatment of Hepatitis C Virus-Lipid Interplay: Pathogenesis

Deglycosylation of the NTD 0.55 mg/ml of enzyme and 1 mg/ml of the purified NTD were incubated on a rotating table at 4C with one of five deglycosylases: PNGase F (hydrolyzes the bond between asparagine and the first N -acetylglucosamine), Endo H (hydrolyzes the glycosidic linkage between the two core N -acetylglucosamines), Endo F1 (cleaves hybrid but not complex oligosaccharides), Endo F2 (leaves one N -acetylglucosamine attached to asparagine), and Endo F3 (does not cleave high mannose or hybrid glycan chains) (66, 67)

direct-acting antiviral agents against hepatitis c virus and lipid metabolism for Treatment of Hepatitis C Virus-Lipid Interplay: Pathogenesis

You may also like

recommand products